AAV Genome Topology Decides ITR Secondary Structure

被引:0
|
作者
Wilmott, Patrick [1 ]
Lisowski, Leszek [1 ,2 ]
机构
[1] Univ Sydney, Childrens Med Res Inst, Fac Med & Hlth, Translat Vectorol Res Unit, Westmead, NSW, Australia
[2] Mil Inst Med Natl Res Inst, Lab Mol Oncol & Innovat Therapies, Warsaw, Poland
关键词
RECOMBINANT ADENOASSOCIATED VIRUS; SITE-SPECIFIC INTEGRATION; VECTOR GENOMES; TRANSGENE EXPRESSION; CRUCIFORM STRUCTURE; INVERTED REPEAT; DNA HELICASE; IN-VIVO; REP68; TRANSDUCTION;
D O I
10.1002/bies.202400266
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Intra-strand base pairing is possible when double-stranded DNA contains inverted repeats, but vanishingly improbable without so-called negative superhelicity. This superhelicity itself is conditional upon whether the molecule can retain torsional stress-a question of "topology." This principle has been uncontroversial to biophysicists since the 1980s but has proven challenging for outsiders to grasp and retain. For those in AAV research, this constitutes a decades-long missed connection. AAV is one of a multitude of viruses bearing secondary-structure-forming elements on their termini. Its "inverted terminal repeats" (ITRs) can self-anneal into relatively large hammerhead structures on both ends of the dynamically structured genome and are central to numerous host interactions that drive the viral lifecycle. A standalone article such as this is therefore warranted to promote an understanding of these ideas in the AAV research community and highlight their significance in the basic biology of the virus and its vector gene delivery system.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Production and Characterization of Infectious Snake AAV Vectors with a Cross-Packaged AAV2-ITR Genome
    Tanaka, Yoshinori
    Takahama, Kazuhiro
    Sairavi, Anusha
    Nakai, Hiroyuki
    MOLECULAR THERAPY, 2018, 26 (05) : 182 - 182
  • [2] Direct ITR-to-ITR Nanopore Sequencing of AAV Vector Genomes
    Namkung, Suk
    Tran, Ngoc Tam
    Manokaran, Sangeetha
    He, Ran
    Su, Qin
    Xie, Jun
    Gao, Guangping
    Tai, Phillip W. L.
    HUMAN GENE THERAPY, 2022, 33 (21-22) : 1187 - 1196
  • [3] Influence of defect ITR on the packaging and infectivity of AAV
    Zuo-Wu, Cao
    Yi, Lin
    Long-Qiu, Cheng
    Fei-Yan, Zou
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2008, 35 (02) : 224 - 230
  • [4] Characterization of the AAV ITR Host Protein Interactome
    Brittain, Tyler
    Borsos, Mate
    Gradinaru, Viviana
    MOLECULAR THERAPY, 2023, 31 (04) : 228 - 228
  • [5] Cross-packaging a vector genome containing densovirus ITR into AAV capsid serotype 2 or 8: possible or not?
    Laugel, M.
    Roblin, A.
    Audrain, C.
    Cheve, C.
    Menard, L.
    Blouin, V.
    Mevel, M.
    Adjali, O.
    Penaud-Budloo, M.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A49 - A50
  • [6] Novel AAV ITR Sequencing and AAV Plasmid Preparation Protocols to Advance Research and Therapies Using AAV Vectors
    Zhao, Jian
    Xiao, Ying
    Kotulak, Kristin
    Leung, Conrad
    MOLECULAR THERAPY, 2020, 28 (04) : 435 - 435
  • [7] Engineering CpG-Free ITR for AAV Gene Therapy
    Pan, Xiufang
    Yue, Yongping
    Wasala, Lakmini
    Zhang, Keqing
    Duan, Dongsheng
    MOLECULAR THERAPY, 2020, 28 (04) : 227 - 227
  • [8] Searching the Hairpin in the Haystack: Tracing the Impact of AAV-ITR Mutations
    Bubeck, Felix
    Baumgartl, Conradin
    Grimm, Dirk
    MOLECULAR THERAPY, 2023, 31 (04) : 96 - 96
  • [9] Quantitative analysis of preferential utilization of AAV ITR as the packaging terminal signal
    Li, Xin
    Miller, Lohra Mickelle
    Chrzanowski, Matthew
    Tian, Jiahe
    Jarrold, Martin F.
    Herzog, Roland W.
    Xiao, Weidong
    Draper, Benjamin
    Zhang, Junping
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2023, 11
  • [10] qPCR for the Detection and Quantification of AAV2 ITR-Sequences
    Aurnhammer, C.
    Haase, M.
    Rauschhuber, C.
    Hausl, M.
    Ehrhardt, A.
    Busch, U.
    Sing, A.
    Huber, I.
    Baiker, A.
    HUMAN GENE THERAPY, 2011, 22 (10) : A95 - A96